Mylène Tajan

Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy

Mylène Tajan, Marc Hennequart, Eric C. Cheung et al. · Nature Communications · 2021 · 305 citations · Full text

Life Sciences, Biochemistry, Oncology +17

A Role for p53 in the Adaptation to Glutamine Starvation through the Expression of SLC1A3

Mylène Tajan, Andreas Hock, Julianna Blagih et al. · Cell Metabolism · 2018 · 228 citations · Full text

Life Sciences, Cell Biology, Oncology +14

Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature

Audrey De Rocca Serra-Nédélec, Thomas Édouard, Karine Tréguer et al. · Proceedings of the National Academy of Sciences · 2012 · 118 citations · Full text

Life Sciences, Endocrinology, Genetics +15

The impact of physiological metabolite levels on serine uptake, synthesis and utilization in cancer cells

Marc Hennequart, Christiaan F. Labuschagne, Mylène Tajan et al. · Nature Communications · 2021 · 69 citations · Full text

Life Sciences, Biochemistry, Cancer Biology +16

LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesity

Mylène Tajan, Aurélie Batut, Thomas Cadoudal et al. · Proceedings of the National Academy of Sciences · 2014 · 59 citations

Life Sciences, Genetics, Molecular Genetics +17